GL1X · GenesisL1 explorer

Research workbench

Crystal structure of hcra-W1266A

Analyse Crystal structure of hcra-W1266A in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4IQP
Type
protein
Length
419 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type a
EC
3.4.24.69
UniProt
P10845
Pockets
3 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin type a (EC 3.4.24.69)protein4196% helix, 45% strandP10845

Ligands and binding sites

  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13930.700.8240GOL
2730.460.8219empty
3570.340.7818empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 4IQP · Crystal Structure of HCRA-W1266A · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.